WOUND GRAFT COMPANY OWNERS SENTENCED FOR $1.2B HEALTH CARE FRAUD AND AGREE TO PAY $309M TO RESOLVE CIVIL LIABILITY UNDER THE FALSE CLAIMS ACT
The following information was released by the
In the first prosecution of its kind, the owners of several
According to court documents, Gehrke, 39, and King, 46, both of
Gehrke referred the patients identified by the sales representatives first to a company she owned, and later in the scheme to a company co-owned by King. Both of these companies were enrolled as Medicare providers and could submit claims to Medicare. Through these companies, Gehrke and King purchased the grafts from a wholesale graft distributor. They also contracted with nurse practitioners to apply the grafts and billed Medicare and other health insurers for the grafts applied. Gehrke and King instructed the nurse practitioners to suspend their medical judgment and apply whatever quantities and sizes of grafts were ordered by the medically untrained sales representatives, regardless of medical necessity.
Gehrke, through the three companies she owned, received over
The financial incentive for the sales representatives to order large numbers and sizes of allografts, combined with Gehrke and King's requirement that nurse practitioners apply all grafts ordered, resulted in large grafts applied to small wounds, several grafts applied to single wounds, grafts applied to non-existent wounds and grafts applied to terminally ill patients receiving palliative care, some of whom died within days or the same day of the allograft application.
Over the course of just 18 months, from
The government seized substantial assets that Gehrke and King accumulated from the scheme, including
Gehrke and Kingpleaded guilty to conspiracy to commit health care fraud and wire fraud on
In addition to the criminal case, Gehrke and the wound graft marketing company she owned,
The Federal Anti-Kickback Statute prohibits offering or paying anything of value to induce referrals of items or services covered by Medicare and other federally funded programs. The statute is intended to ensure that the judgment of medical providers is not compromised by improper financial incentives.
The False Claims Act allegations resolved by the civil settlements were originally brought by whistleblowers under the qui tam provisions of the False Claims Act, which allow private parties to bring suit on behalf of the government and to share in any recovery. The matters remain under seal while the investigation of other parties continues. The amount of the whistleblower shares of the settlements has not yet been determined.
The FBI, HHS-OIG,
Trial Attorney



SENATOR BLUMENTHAL: WEEK IN REVIEW 12/5/2025-12/12/2025
WAGE GROWTH TRACKER 4.1 PERCENT
Advisor News
- Sketching out the golden years: new book tries to make retirement planning fun
- Most women say they are their household’s CFO, Allianz Life survey finds
- MassMutual reports strong 2025 results
- The silent retirement savings killer: Bridging the Medicare gap
- LTC: A critical component of retirement planning
More Advisor NewsAnnuity News
- Advising clients wanting to retire early: how annuities can bridge the gap
- F&G joins Voya’s annuity platform
- Regulators ponder how to tamp down annuity illustrations as high as 27%
- Annual annuity reviews: leverage them to keep clients engaged
- Symetra Enhances Fixed Indexed Annuities, Introduces New Franklin Large Cap Value 15% ER Index
More Annuity NewsHealth/Employee Benefits News
- Study Results from Johns Hopkins University Broaden Understanding of Managed Care (Medicare Advantage Networks for Surgical Specialists): Managed Care
- How Personal Injury Claims Affect Future Health Insurance Coverage in Charlotte, NC
- New Dementia Data Have Been Reported by Researchers at National Health Insurance Service (Central Nervous System Medication Use Among Older Adults in Korean Long-Term Care Facilities: A Multilevel Analysis): Neurodegenerative Diseases and Conditions – Dementia
- States try 'public option' Obamacare plans to reduce coverage costs
- Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
More Health/Employee Benefits NewsLife Insurance News
- Majority of Women Now Are the Chief Financial Officer of Their Household, Allianz Life Study Finds
- Most women say they are their household’s CFO, Allianz Life survey finds
- MassMutual Delivers Excellent 2025 Financial Results
- ACORE CAPITAL Named Alternative Lender of the Year ($15 Billion + AUM) by PERE Credit
- Baby on Board
More Life Insurance News